Document Detail

Delayed cardioprotective effects of exercise in dogs are aminoguanidine sensitive: possible involvement of nitric oxide.
MedLine Citation:
PMID:  11914106     Owner:  NLM     Status:  MEDLINE    
Dogs were subjected to exercise on a treadmill, using a protocol in which the speed and slope were increased every 3 min, and which elevated both heart rate (to a mean of 198+/-14 beats.min(-1)) and mean arterial blood pressure (to 150+/-4 mmHg). Then, 24 or 48 h later, the dogs were anaesthetized with a mixture of alpha-chloralose and urethane and subjected to a 25 min occlusion of the left anterior descending coronary artery. The control dogs (instrumented but not exercised) were subjected to the same procedure. In some dogs the nitric oxide synthase inhibitor aminoguanidine (50; intravenous) was administered 30 min before occlusion. Baroreflex sensitivity (BRS) was determined by the rapid bolus injection of phenylephrine 60 min before, and again 3 min after, the onset of occlusion. Exercise markedly reduced the consequences of coronary artery occlusion 24 h (but not 48 h) later, without modifying myocardial tissue blood flow. In the exercised dogs there were reductions in arrhythmia severity [ventricular fibrillation (VF) during occlusion, 0%; survival from the combined ischaemia/reperfusion insult, 70%] compared with controls (VF during occlusion, 36%; survival, 9%). BRS was preserved during occlusion in the exercised dogs (before occlusion, 1.60+/-0.54 ms.mmHg(-1); 3 min after occlusion, 1.37+/-0.4 ms.mmHg(-1)), but not in controls (before occlusion, 1.28+/-0.29 ms.mmHg(-1); 3 min after occlusion, 0.45+/-0.12 ms.mmHg(-1); P<0.05), and other ischaemic changes (inhomogeneity of electrical activation and changes in the ST-segment, recorded over the ischaemic region) were also less marked in the exercised dogs. Exercise-induced cardioprotection was abolished by aminoguanidine (VF during occlusion, 25%; survival, 0%). The results show that even a single period of exercise affords delayed protection against ischaemia/reperfusion-induced VF and other ischaemic changes. Since this protection is abolished by aminoguanidine, and since (inducible) NO synthase activity was elevated 3-fold in left ventricular samples 24 h after exercise, we suggest that this protection is mediated by nitric oxide.
László Babai; Zsolt Szigeti; James R Parratt; Agnes Végh
Related Documents :
21200106 - Electromagnetic interference with electrocardiogram recording of exercise test equipment.
6856966 - Prolonged depletion of atp because of delayed repletion of the adenine nucleotide pool ...
10385506 - Additive effects of late preconditioning produced by monophosphoryl lipid a and the ear...
17280486 - Characterization of in vivo tissue redox status, oxygenation, and formation of reactive...
15705646 - Exercise in the fasted state facilitates fibre type-specific intramyocellular lipid bre...
8444696 - Effects of acute and chronic acetazolamide on resting ventilation and ventilatory respo...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Clinical science (London, England : 1979)     Volume:  102     ISSN:  0143-5221     ISO Abbreviation:  Clin. Sci.     Publication Date:  2002 Apr 
Date Detail:
Created Date:  2002-03-26     Completed Date:  2002-06-21     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7905731     Medline TA:  Clin Sci (Lond)     Country:  England    
Other Details:
Languages:  eng     Pagination:  435-45     Citation Subset:  IM    
Department of Pharmacology and Pharmacotherapy, University of Szeged, Albert Szent-Györgyi Faculty of Medicine, Dóm tér 12, P.O. Box 427, H-6701 Szeged, Hungary.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Baroreflex / physiology
Coronary Circulation / physiology
Coronary Disease / complications,  physiopathology
Enzyme Inhibitors / pharmacology
Guanidines / pharmacology
Heart Ventricles / enzymology
Myocardial Reperfusion Injury / prevention & control*
Nitric Oxide / physiology*
Nitric Oxide Synthase / antagonists & inhibitors,  metabolism
Physical Conditioning, Animal / physiology*
Ventricular Fibrillation / etiology,  prevention & control*
Reg. No./Substance:
0/Enzyme Inhibitors; 0/Guanidines; 10102-43-9/Nitric Oxide; 79-17-4/pimagedine; EC Oxide Synthase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effect of prothrombin and its activation fragments on calcium oxalate crystal growth and aggregation...
Next Document:  A European multicentre, placebo-controlled supplementation study with alpha-tocopherol, carotene-ric...